Good. Leaves room for the share price to grow rather than new shares coming and getting dumped asap, killing the stock.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025